The pathogenic gene mutations subgroup had a significantly higher number of cancers with high nuclear grade (6 of 17 [35.3%], p = 0.017), ER negative (7 of 17 [41.2%], p = 0.004), and PR negative (7 of 17 [41.2%], p = 0.007). The gene discussed is ESR1; the disease is cancer.